Gastrointestinal Stromal Tumors (GIST) Registry
1 other identifier
observational
1,800
1 country
1
Brief Summary
The goal of this observational research study is to establish a registry of information regarding how different physicians treat and manage patients with gastrointestinal stromal tumors (GISTs). Objectives:
- 1.To describe variation in management of patients with GIST, overall and by patient and provider characteristics.
- 2.To provide participating physicians with information regarding management of their patients with GIST compared to the aggregate experience of all physicians participating in the Registry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 25, 2007
CompletedFirst Posted
Study publicly available on registry
July 26, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedAugust 2, 2012
August 1, 2012
5.3 years
July 25, 2007
August 1, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Current patterns of medical practice in management of patients with GIS
Data from observational GIST Registry analyzed to describe current patterns.
5 Years
Study Arms (1)
GIST
Patients diagnosed with a gastrointestinal stromal tumor (GIST)
Interventions
Internet based data registry about how different physicians treat and manage patients with gastrointestinal stromal tumors.
Eligibility Criteria
Patients diagnosed with a gastrointestinal stromal tumor (GIST).
You may qualify if:
- \. All patients who have been diagnosed with GIST are eligible for enrollment.
You may not qualify if:
- \. Patients with a histologic diagnosis other than gastrointestinal stromal tumor (GIST).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- Novartis Pharmaceuticalscollaborator
Study Sites (1)
UT MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Publications (1)
Pisters PWT, Blanke CD, von Mehren M, Picus J, Sirulnik A, Stealey E, Trent JC; reGISTry Steering Committee. A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices. Ann Oncol. 2011 Nov;22(11):2523-2529. doi: 10.1093/annonc/mdq773. Epub 2011 Apr 4.
PMID: 21464155DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathon Trent, MD, PhD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2007
First Posted
July 26, 2007
Study Start
August 1, 2005
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
August 2, 2012
Record last verified: 2012-08